Leveraging Active Diagnostic Stewardship Interventions to Optimize the Outcomes of Patients with Bacteremia

Life Sciences, Medical Device, Healthcare, Medical Device Diagnostics, Laboratory Technology,
  • Thursday, May 30, 2024 | 1pm EDT (12pm CDT / 10am PDT)
  • 60 min

Bloodstream infections are a common cause of morbidity and mortality despite advances in antimicrobial agents and sepsis management. Over the past decade, several molecular methods have been integrated into routine clinical microbiology workflows due to their ability to rapidly and simultaneously detect microorganisms and antimicrobial resistance genes from positive blood cultures.

Incorporating a rapid multiplex molecular blood culture identification (BCID) panel can be an important strategy to improve the outcomes of patients with bacteremia and improve antimicrobial utilization. However, the impact on clinical outcomes is only realized when rapid BCID results are partnered with active stewardship interventions.

In this webinar, the expert speaker will share insights gained through the implementation of a rapid syndromic cobas® eplex BCID panels in tandem with real-time antimicrobial stewardship interventions, which resulted in improved antimicrobial use and patient outcomes at a large academic medical center.

This webinar focuses on the integration of rapid blood culture identification into an antimicrobial stewardship program, how antimicrobial stewardship programs make rapid BCID results actionable and how the results can be used to demonstrate the value of the test and impact on antimicrobial stewardship.

Register for this webinar today to understand how active diagnostic stewardship interventions can help optimize the outcomes of patients with bacteremia.


Ryan Shields, University of Pittsburgh,

Ryan Shields, PharmD, MS, Associate Professor of Medicine, University of Pittsburgh, Department of Medicine

Ryan Shields is an Infectious Diseases pharmacist and Associate Professor in the Department of Medicine, Division of Infectious Diseases. He serves as the Director of UPMC Presbyterian Antibiotic Management Program and Co-Director of the Center for Innovative Antimicrobial Therapy at the University of Pittsburgh. Dr. Shields is also the Founder and Co-Director of the PRECEDENT network, a real-world comparative-effectiveness research network. He is actively engaged in the diagnosis and management of patients infected by multi-drug resistant bacteria. His laboratory focuses on the characterization and suppression of antimicrobial resistance by using molecular markers to predict patient responses and PK-PD pre-clinical models to study novel antibiotic approaches. Dr. Shields’ clinical and research roles have focused on designing individualized treatment regimens for patients infected by MDR pathogens, the emergence of resistance to new antimicrobial agents and developing innovative stewardship approaches to implement molecular diagnostic tests.

Message Presenter

Who Should Attend?

This webinar will appeal to the following professionals:

  • Pharmacists
  • Physicians
  • Infectious Disease Clinicians
  • Antimicrobial Stewardship Committee Members
  • Hospital Administrators (i.e., C-suite)
  • Nurses
  • Laboratory Directors and Managers

What You Will Learn

Attendees will learn:

  • How one institution successfully implemented a rapid multiplex blood culture identification panel into their antimicrobial stewardship program
  • How rapid blood culture identification results can improve the management of patients with bacteremia
  • How to identify outcomes that can be used to demonstrate the value of rapid blood culture identification

Xtalks Partner


Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche a leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

With the addition of the cobas® eplex System, Roche expands its portfolio to multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. The cobas® eplex System, a true sample-to-answer solution, is designed for the patient and optimized for the laboratory. The cobas® eplex System addresses respiratory and bloodstream infections with compact, easy-to-use workstations and self-contained test cartridges. The company’s headquarters are located in Carlsbad, CA.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account